Table of Content

1. Executive Summary
   1.1. Global Liposomes Market Snapshot, 2025 and 2032
   1.2. Market Opportunity Assessment, 2025 - 2032, US$ Mn
   1.3. Key Market Trends
   1.4. Future Market Projections
   1.5. Premium Market Insights
   1.6. Industry Developments and Key Market Events
   1.7. PMR Analysis and Recommendations
2. Market Overview
   2.1. Market Scope and Definition
   2.2. Market Dynamics
       2.2.1. Drivers
       2.2.2. Restraints
       2.2.3. Opportunity
       2.2.4. Challenges
       2.2.5. Key Trends
   2.3. Macro-Economic Factors
       2.3.1. Global Sectorial Outlook
       2.3.2. Global GDP Growth Outlook
   2.4. COVID-19 Impact Analysis
   2.5. Forecast Factors - Relevance and Impact
3. Value Added Insights
   3.1. Regulatory Landscape
   3.2. Product Adoption Analysis
   3.3. Value Chain Analysis
   3.4. Key Deals and Mergers
   3.5. PESTLE Analysis
   3.6. Porter’s Five Force Analysis
4. Global Liposomes Market Outlook: Historical (2019 - 2024) and Forecast (2025 - 2032)
   4.1. Key Highlights
       4.1.1. Market Size (US$ Mn) and Y-o-Y Growth
       4.1.2. Absolute $ Opportunity
   4.2. Market Size (US$ Mn) Analysis and Forecast
       4.2.1. Historical Market Size (US$ Mn) Analysis, 2019-2024
       4.2.2. Current Market Size (US$ Mn) Analysis and Forecast, 2025-2032
   4.3. Global Liposomes Market Outlook: Product
       4.3.1. Introduction / Key Findings
       4.3.2. Historical Market Size (US$ Mn) Analysis, By Product, 2019 - 2024
       4.3.3. Current Market Size (US$ Mn) Analysis and Forecast, By Product, 2025 - 2032
           4.3.3.1. Simple Liposomes
           4.3.3.2. Formulated Liposomes
               4.3.3.2.1. Doxorubicin Liposomes
               4.3.3.2.2. Amphotericin B Liposomes
               4.3.3.2.3. Paclitaxel Liposomes
               4.3.3.2.4. Cytarabine Liposomes
               4.3.3.2.5. Irinotecan Liposomes
               4.3.3.2.6. Cisplatin Liposomes
               4.3.3.2.7. Others
           4.3.3.3. Vaccines
       4.3.4. Market Attractiveness Analysis: Product
   4.4. Global Liposomes Market Outlook: Application
       4.4.1. Introduction / Key Findings
       4.4.2. Historical Market Size (US$ Mn) Analysis, By Application, 2019 - 2024
       4.4.3. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2025 - 2032
           4.4.3.1. Retail Sales
               4.4.3.1.1. Academic & Research Laboratories
               4.4.3.1.2. Biopharmaceutical Companies
               4.4.3.1.3. Clinical Research Organizations
               4.4.3.1.4. Others
           4.4.3.2. Distribution Sales
               4.4.3.2.1. Hospital Pharmacies
               4.4.3.2.2. Retail Pharmacies
               4.4.3.2.3. Mail Order Pharmacies
               4.4.3.2.4. Drug Stores
       4.4.4. Market Attractiveness Analysis: Application
   4.5. Global Liposomes Market Outlook: Distribution Channel
       4.5.1. Introduction / Key Findings
       4.5.2. Historical Market Size (US$ Mn) Analysis, By Distribution Channel, 2019 - 2024
       4.5.3. Current Market Size (US$ Mn) Analysis and Forecast, By Distribution Channel, 2025 - 2032
           4.5.3.1. Oral
           4.5.3.2. Injectable
           4.5.3.3. Others
       4.5.4. Market Attractiveness Analysis: Distribution Channel
5. Global Liposomes Market Outlook: Region
   5.1. Key Highlights
   5.2. Historical Market Size (US$ Mn) Analysis, By Region, 2019 - 2024
   5.3. Current Market Size (US$ Mn) Analysis and Forecast, By Region, 2025 - 2032
       5.3.1. North America
       5.3.2. Europe
       5.3.3. East Asia
       5.3.4. South Asia and Oceania
       5.3.5. Latin America
       5.3.6. Middle East & Africa
   5.4. Market Attractiveness Analysis: Region
6. North America Liposomes Market Outlook: Historical (2019 - 2024) and Forecast (2025 - 2032)
   6.1. Key Highlights
   6.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019 - 2024
       6.2.1. By Country
       6.2.2. By Product
       6.2.3. By Application
       6.2.4. By Distribution Channel
   6.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025 - 2032
       6.3.1. U.S.
       6.3.2. Canada
   6.4. Current Market Size (US$ Mn) Analysis and Forecast, By Product, 2025 - 2032
       6.4.1. Simple Liposomes
       6.4.2. Formulated Liposomes
           6.4.2.1. Doxorubicin Liposomes
           6.4.2.2. Amphotericin B Liposomes
           6.4.2.3. Paclitaxel Liposomes
           6.4.2.4. Cytarabine Liposomes
           6.4.2.5. Irinotecan Liposomes
           6.4.2.6. Cisplatin Liposomes
           6.4.2.7. Others
       6.4.3. Vaccines
   6.5. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2025 - 2032
       6.5.1. Drug delivery
           6.5.1.1. Cancer
           6.5.1.2. Fungal Infection
           6.5.1.3. Viral & Parasite Infection
           6.5.1.4. Others
       6.5.2. Gene Delivery/Transfection
       6.5.3. Contrast agents for medical imaging
       6.5.4. Model Cell Membranes
   6.6. Current Market Size (US$ Mn) Analysis and Forecast, By Distribution Channel, 2025 - 2032
       6.6.1. Retail Sales
           6.6.1.1. Academic & Research Laboratories
           6.6.1.2. Biopharmaceutical Companies
           6.6.1.3. Clinical Research Organizations
           6.6.1.4. Others
       6.6.2. Distribution Sales
           6.6.2.1. Hospital Pharmacies
           6.6.2.2. Retail Pharmacies
           6.6.2.3. Mail Order Pharmacies
           6.6.2.4. Drug Stores
   6.7. Market Attractiveness Analysis
7. Europe Liposomes Market Outlook: Historical (2019 - 2024) and Forecast (2025 - 2032)
   7.1. Key Highlights
   7.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019 - 2024
       7.2.1. By Country
       7.2.2. By Product
       7.2.3. By Application
       7.2.4. By Distribution Channel
   7.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025 - 2032
       7.3.1. Germany
       7.3.2. France
       7.3.3. U.K.
       7.3.4. Italy
       7.3.5. Spain
       7.3.6. Russia
       7.3.7. Türkiye
       7.3.8. Rest of Europe
   7.4. Current Market Size (US$ Mn) Analysis and Forecast, By Product, 2025 - 2032
       7.4.1. Simple Liposomes
       7.4.2. Formulated Liposomes
           7.4.2.1. Doxorubicin Liposomes
           7.4.2.2. Amphotericin B Liposomes
           7.4.2.3. Paclitaxel Liposomes
           7.4.2.4. Cytarabine Liposomes
           7.4.2.5. Irinotecan Liposomes
           7.4.2.6. Cisplatin Liposomes
           7.4.2.7. Others
       7.4.3. Vaccines
   7.5. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2025 - 2032
       7.5.1. Drug delivery
           7.5.1.1. Cancer
           7.5.1.2. Fungal Infection
           7.5.1.3. Viral & Parasite Infection
           7.5.1.4. Others
       7.5.2. Gene Delivery/Transfection
       7.5.3. Contrast agents for medical imaging
       7.5.4. Model Cell Membranes
   7.6. Current Market Size (US$ Mn) Analysis and Forecast, By Distribution Channel, 2025 - 2032
       7.6.1. Retail Sales
           7.6.1.1. Academic & Research Laboratories
           7.6.1.2. Biopharmaceutical Companies
           7.6.1.3. Clinical Research Organizations
           7.6.1.4. Others
       7.6.2. Distribution Sales
           7.6.2.1. Hospital Pharmacies
           7.6.2.2. Retail Pharmacies
           7.6.2.3. Mail Order Pharmacies
           7.6.2.4. Drug Stores
   7.7. Market Attractiveness Analysis
8. East Asia Liposomes Market Outlook: Historical (2019 - 2024) and Forecast (2025 - 2032)
   8.1. Key Highlights
   8.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019 - 2024
       8.2.1. By Country
       8.2.2. By Product
       8.2.3. By Application
       8.2.4. By Distribution Channel
   8.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025 - 2032
       8.3.1. China
       8.3.2. Japan
       8.3.3. South Korea
   8.4. Current Market Size (US$ Mn) Analysis and Forecast, By Product, 2025 - 2032
       8.4.1. Simple Liposomes
       8.4.2. Formulated Liposomes
           8.4.2.1. Doxorubicin Liposomes
           8.4.2.2. Amphotericin B Liposomes
           8.4.2.3. Paclitaxel Liposomes
           8.4.2.4. Cytarabine Liposomes
           8.4.2.5. Irinotecan Liposomes
           8.4.2.6. Cisplatin Liposomes
           8.4.2.7. Others
       8.4.3. Vaccines
   8.5. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2025 - 2032
       8.5.1. Drug delivery
           8.5.1.1. Cancer
           8.5.1.2. Fungal Infection
           8.5.1.3. Viral & Parasite Infection
           8.5.1.4. Others
       8.5.2. Gene Delivery/Transfection
       8.5.3. Contrast agents for medical imaging
       8.5.4. Model Cell Membranes
   8.6. Current Market Size (US$ Mn) Analysis and Forecast, By Distribution Channel, 2025 - 2032
       8.6.1. Retail Sales
           8.6.1.1. Academic & Research Laboratories
           8.6.1.2. Biopharmaceutical Companies
           8.6.1.3. Clinical Research Organizations
           8.6.1.4. Others
       8.6.2. Distribution Sales
           8.6.2.1. Hospital Pharmacies
           8.6.2.2. Retail Pharmacies
           8.6.2.3. Mail Order Pharmacies
           8.6.2.4. Drug Stores
   8.7. Market Attractiveness Analysis
9. South Asia & Oceania Liposomes Market Outlook: Historical (2019 - 2024) and Forecast (2025 - 2032)
   9.1. Key Highlights
   9.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019 - 2024
       9.2.1. By Country
       9.2.2. By Product
       9.2.3. By Application
       9.2.4. By Distribution Channel
   9.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025 - 2032
       9.3.1. India
       9.3.2. Southeast Asia
       9.3.3. ANZ
       9.3.4. Rest of South Asia & Oceania
   9.4. Current Market Size (US$ Mn) Analysis and Forecast, By Product, 2025 - 2032
       9.4.1. Simple Liposomes
       9.4.2. Formulated Liposomes
           9.4.2.1. Doxorubicin Liposomes
           9.4.2.2. Amphotericin B Liposomes
           9.4.2.3. Paclitaxel Liposomes
           9.4.2.4. Cytarabine Liposomes
           9.4.2.5. Irinotecan Liposomes
           9.4.2.6. Cisplatin Liposomes
           9.4.2.7. Others
       9.4.3. Vaccines
   9.5. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2025 - 2032
       9.5.1. Drug delivery
           9.5.1.1. Cancer
           9.5.1.2. Fungal Infection
           9.5.1.3. Viral & Parasite Infection
           9.5.1.4. Others
       9.5.2. Gene Delivery/Transfection
       9.5.3. Contrast agents for medical imaging
       9.5.4. Model Cell Membranes
   9.6. Current Market Size (US$ Mn) Analysis and Forecast, By Distribution Channel, 2025 - 2032
       9.6.1. Retail Sales
           9.6.1.1. Academic & Research Laboratories
           9.6.1.2. Biopharmaceutical Companies
           9.6.1.3. Clinical Research Organizations
           9.6.1.4. Others
       9.6.2. Distribution Sales
           9.6.2.1. Hospital Pharmacies
           9.6.2.2. Retail Pharmacies
           9.6.2.3. Mail Order Pharmacies
           9.6.2.4. Drug Stores
   9.7. Market Attractiveness Analysis
10. Latin America Liposomes Market Outlook: Historical (2019 - 2024) and Forecast (2025 - 2032)
   10.1. Key Highlights
   10.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019 - 2024
       10.2.1. By Country
       10.2.2. By Product
       10.2.3. By Application
       10.2.4. By Distribution Channel
   10.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025 - 2032
       10.3.1. Brazil
       10.3.2. Mexico
       10.3.3. Rest of Latin America
   10.4. Current Market Size (US$ Mn) Analysis and Forecast, By Product, 2025 - 2032
       10.4.1. Simple Liposomes
       10.4.2. Formulated Liposomes
           10.4.2.1. Doxorubicin Liposomes
           10.4.2.2. Amphotericin B Liposomes
           10.4.2.3. Paclitaxel Liposomes
           10.4.2.4. Cytarabine Liposomes
           10.4.2.5. Irinotecan Liposomes
           10.4.2.6. Cisplatin Liposomes
           10.4.2.7. Others
       10.4.3. Vaccines
   10.5. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2025 - 2032
       10.5.1. Drug delivery
           10.5.1.1. Cancer
           10.5.1.2. Fungal Infection
           10.5.1.3. Viral & Parasite Infection
           10.5.1.4. Others
       10.5.2. Gene Delivery/Transfection
       10.5.3. Contrast agents for medical imaging
       10.5.4. Model Cell Membranes
   10.6. Current Market Size (US$ Mn) Analysis and Forecast, By Distribution Channel, 2025 - 2032
       10.6.1. Retail Sales
           10.6.1.1. Academic & Research Laboratories
           10.6.1.2. Biopharmaceutical Companies
           10.6.1.3. Clinical Research Organizations
           10.6.1.4. Others
       10.6.2. Distribution Sales
           10.6.2.1. Hospital Pharmacies
           10.6.2.2. Retail Pharmacies
           10.6.2.3. Mail Order Pharmacies
           10.6.2.4. Drug Stores
   10.7. Market Attractiveness Analysis
11. Middle East & Africa Liposomes Market Outlook: Historical (2019 - 2024) and Forecast (2025 - 2032)
   11.1. Key Highlights
   11.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019 - 2024
       11.2.1. By Country
       11.2.2. By Product
       11.2.3. By Application
       11.2.4. By Distribution Channel
   11.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025 - 2032
       11.3.1. GCC Countries
       11.3.2. Egypt
       11.3.3. South Africa
       11.3.4. Northern Africa
       11.3.5. Rest of Middle East & Africa
   11.4. Current Market Size (US$ Mn) Analysis and Forecast, By Product, 2025 - 2032
       11.4.1. Simple Liposomes
       11.4.2. Formulated Liposomes
           11.4.2.1. Doxorubicin Liposomes
           11.4.2.2. Amphotericin B Liposomes
           11.4.2.3. Paclitaxel Liposomes
           11.4.2.4. Cytarabine Liposomes
           11.4.2.5. Irinotecan Liposomes
           11.4.2.6. Cisplatin Liposomes
           11.4.2.7. Others
       11.4.3. Vaccines
   11.5. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2025 - 2032
       11.5.1. Drug delivery
           11.5.1.1. Cancer
           11.5.1.2. Fungal Infection
           11.5.1.3. Viral & Parasite Infection
           11.5.1.4. Others
       11.5.2. Gene Delivery/Transfection
       11.5.3. Contrast agents for medical imaging
       11.5.4. Model Cell Membranes
   11.6. Current Market Size (US$ Mn) Analysis and Forecast, By Distribution Channel, 2025 - 2032
       11.6.1. Retail Sales
           11.6.1.1. Academic & Research Laboratories
           11.6.1.2. Biopharmaceutical Companies
           11.6.1.3. Clinical Research Organizations
           11.6.1.4. Others
       11.6.2. Distribution Sales
           11.6.2.1. Hospital Pharmacies
           11.6.2.2. Retail Pharmacies
           11.6.2.3. Mail Order Pharmacies
           11.6.2.4. Drug Stores
   11.7. Market Attractiveness Analysis
12. Competition Landscape
   12.1. Market Share Analysis, 2024
   12.2. Market Structure
       12.2.1. Competition Intensity Mapping By Market
       12.2.2. Competition Dashboard
   12.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
       12.3.1. Novartis AG (Liposoma BV)
           12.3.1.1. Overview
           12.3.1.2. Segments and Products
           12.3.1.3. Key Financials
           12.3.1.4. Market Developments
           12.3.1.5. Market Strategy
       12.3.2. Precision NanoSystems Inc
       12.3.3. Janssen Pharmaceutical Companies (Johnson & Johnson)
       12.3.4. Encapsula Nano Sciences
       12.3.5. Synpac-Kingdom Pharmaceutical Co., Ltd
       12.3.6. Celsion GmbH
       12.3.7. Gilead Sciences, Inc
       12.3.8. Pacira BioSciences, Inc.
       12.3.9. Luye Pharma Group
       12.3.10. Sun Pharma Industries Ltd
       12.3.11. Shanghai New Asia Pharmaceutical Co., Ltd.
       12.3.12. ENERGY DELIVERY SOLUTIONs
       12.3.13. Creative Biolabs
       12.3.14. Nanovex Biotechnologies SL
       12.3.15. Insys Therapeutics Inc
       12.3.16. Fujifilm Holdings Corporation
       12.3.17. Virpax Pharmaceuticals
       12.3.18. Azaya Therapeutics
       12.3.19. Avanti Polar Lipids, Inc.
       12.3.20. Breath Therapeutics (Zambon company)
       12.3.21. Getwell
       12.3.22. Taiwan Liposome Company Ltd
       12.3.23. Fresenius Health Care Group
       12.3.24. Xellia Pharmaceuticals (Novo Holdings A/S)
       12.3.25. Jazz Pharmaceuticals plc
       12.3.26. Ipsen Biopharmaceuticals, Inc.
       12.3.27. Baxter
       12.3.28. GMPriority Pharma
       12.3.29. S. G. Biopharm Pvt. Ltd
13. Appendix
   13.1. Research Methodology
   13.2. Research Assumptions
   13.3. Acronyms and Abbreviations